Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)
Publication Title
SITC 2021
Authors
Brie Chun, Earle A. Chiles Research Institute, 4805 N.E. Glisan St., North Tower, Suite 2N87, Portland, OR, 97213, USA.Follow
Joanna Pucilowska, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, ORFollow
Shu-Ching Chang, Medical Data Research Center, Providence Health & Services, Portland, OR, USAFollow
Isaac Kim, Earle A. Chiles Research Institute, 4805 N.E. Glisan St., North Tower, Suite 2N87, Portland, OR, 97213, USA.Follow
Benjamin Nikitin, ProvidenceFollow
Yoshinobu Koguchi, Robert W Franz Cancer Center, Earle A Chiles Research Institute, Portland, OR, USAFollow
William L. Redmond, Earle A Chiles Research InstituteFollow
Brady Bernard, Institute for Systems Biology, Seattle, WA 98109.Follow
Venkatesh Rajamanickam, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, ORFollow
Nathan Polaske
Paul Fields
Valerie Conrad, Earle A. Chiles Research Institute, Portland, OR; Providence Cancer Institute, Portland, ORFollow
Mark Schmidt, Providence Cancer Institute, Portland, ORFollow
Walter Urba, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, 97213, USA.Follow
Alison Conlin, Providence Cancer Center, Portland, Oregon.Follow
Heather McArthur
David B Page, Providence Cancer Center, Earle A. Chiles Research Institute Portland , OR , USAFollow
Document Type
Presentation
Keywords
oregon; washington
Clinical Institute
Cancer
Clinical Institute
Women & Children
Specialty/Research Institute
Oncology
